GKWIM
CPHR

Gerber Kawasaki Wealth & Investment Management’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,500
Closed -$49K – 86
2015
Q4 		$49K Buy
+10,500
New +$45.4K 0.03% 79

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's CPHR Position: Q1 2016 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q1 2016, closing a stake of 10,500 shares — an estimated $49K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in CPHR in Q4 2015 and held it in 1 quarter. The position peaked at $49K in Q4 2015. 19 funds tracked by Wall St. Rank hold CPHR as of Q1 2016.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Cipher Pharmaceuticals Inc. position as of Q1 2016 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 10,500 Cipher Pharmaceuticals Inc. shares in Q1 2016, an estimated $49K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Cipher Pharmaceuticals Inc. in Q4 2015 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Cipher Pharmaceuticals Inc. position peaked at $49K in Q4 2015.
  • 19 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q1 2016.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q1 2016, filed 5 May 2016.